• Aribiolab issued a correction to its May 14 disclosure on the issuance of its 6th private convertible bond.
• Revision updates parts of the call option terms following discussions with the investor.
• Call option exercise schedule was changed to five windows starting May 17–May 31, 2027, with settlement June 5, 2027.
• Revised call prices range from 106.2003% to 108.3516% of principal across the updated exercise windows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aribiolab Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000335), on September 28, 2026, and is solely responsible for the information contained therein.